Injection site guidance
Injection sites by medicine: what the manufacturers say
GLPMGR only offers and draws injection areas that a medicine’s manufacturer lists, using the approved product information for your region. Choose a medicine below for the areas the manufacturer lists in the UK, the EU and the US, any “another person should inject” or belly-button rules, the manufacturer’s rotation wording and the source documents.
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the shading shows where you've injected before. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.
Mounjaro (tirzepatide) injection sites
Manufacturer: Eli Lilly
- United Kingdom: Abdomen, Thigh, Back of upper arm (another person)
- European Union: Abdomen, Thigh, Back of upper arm (another person)
- United States: Abdomen, Thigh, Back of upper arm (another person)
Wegovy (semaglutide) injection sites
Manufacturer: Novo Nordisk
- United Kingdom: Abdomen, Thigh, Upper arm
- European Union: Abdomen, Thigh, Back of upper arm (another person)
- United States: Abdomen, Thigh, Back of upper arm (another person)
Ozempic (semaglutide) injection sites
Manufacturer: Novo Nordisk
- United Kingdom: Abdomen, Thigh, Upper arm
- European Union: Abdomen, Thigh, Back of upper arm (another person)
- United States: Abdomen, Thigh, Back of upper arm (another person)
Saxenda (liraglutide) injection sites
Manufacturer: Novo Nordisk
- United Kingdom: Abdomen, Thigh, Upper arm
- European Union: Abdomen, Thigh, Upper arm
- United States: Abdomen, Thigh, Upper arm
Trulicity (dulaglutide) injection sites
Manufacturer: Eli Lilly
- United Kingdom: Abdomen, Thigh, Upper arm (another person)
- European Union: Abdomen, Thigh, Upper arm (another person)
- United States: Abdomen, Thigh, Back of upper arm (another person)
Zepbound (tirzepatide) injection sites
Manufacturer: Eli Lilly
- United Kingdom: no verified list
- European Union: no verified list
- United States: Abdomen, Thigh, Back of upper arm (another person)
Victoza (liraglutide) injection sites
Manufacturer: Novo Nordisk
- United Kingdom: Abdomen, Thigh, Upper arm
- European Union: Abdomen, Thigh, Upper arm
- United States: Abdomen, Thigh, Upper arm (another person)
How the app uses this
- Only the areas listed for your medicine, in your region, can be chosen or shown on the body map.
- Where the manufacturer says another person should inject an area, or to keep a distance from the belly button, the app shows that beside the area.
- Your injection history only colours the body map to show where you have injected before. It never adds an area, and GLPMGR does not tell you where to inject next.
- If we don’t hold a verified list for a medicine in your region, GLPMGR doesn’t offer a site. This includes compounded medicines (made up by a pharmacy rather than the manufacturer), which the manufacturer’s instructions don’t cover, and medicines you type in yourself.
- A medicine named only by its active ingredient gets a list only when every product with that ingredient sold in your region has a verified list and they all give the same rules.
- Earlier injections recorded at other sites, such as the glutes, stay in your history but are not shown on the map.
Which documents
The United Kingdom lists come from each manufacturer’s approved leaflet, as published by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s medicines regulator. The European Union lists come from the European Medicines Agency (EMA) product information. The United States lists come from labels approved by the US Food and Drug Administration (FDA), published on DailyMed. What these names mean. The rules can differ between regions, so GLPMGR uses only the region you choose in Settings, or your device’s region. Where a region’s document has not been checked yet, or is being re-checked because it changed, it says so on the medicine’s page and no sites are offered. Every list is checked again against its source regularly, and GLPMGR stops using any list that has not been re-checked in over a year.
All sources
Every document these lists were taken from or checked against, by region. Documents marked “also consulted” were read and agree with the list, but the list follows the first document for each medicine.
United Kingdom
- MHRA products database / Eli Lilly: Mounjaro KwikPen solution for injection in pre-filled pen, package leaflet with Instructions for Use (PLGB 14895/0341; leaflet last revised July 2026, Instructions for Use May 2025) — Mounjaro
- MHRA product search: look for Wegovy FlexTouch, package leaflet with Instructions for Use, PLGB 04668/0440, last revised 08/2026 — Wegovy
- MHRA products database / Novo Nordisk: Ozempic solution for injection in pre-filled pen, package leaflet (PLGB 04668/0333, last revised 11/2025) — Ozempic
- MHRA products database / Novo Nordisk: Saxenda 6 mg/ml solution for injection in pre-filled pen, package leaflet (PLGB 04668/0409, last revised 08/2025) — Saxenda
- MHRA products database / Eli Lilly: Trulicity 4.5 mg solution for injection in pre-filled pen, package leaflet with Instructions for Use (PLGB 14895/0262, last revised February 2026) — Trulicity
- MHRA products database / Abacus Medicine Ltd: Victoza 6 mg/ml solution for injection in pre-filled pen, package leaflet (PL 45763/1340, last revised 11/02/2025) — Victoza
- MHRA products database / Novo Nordisk A/S: Victoza 6 mg/ml solution for injection in pre-filled pen, Summary of Product Characteristics (PLGB 04668/0413, text revised 04/11/2024) — Victoza (also consulted)
- MHRA products database / Orifarm UK Ltd: Victoza 6 mg/ml pre-filled pen, package leaflet (PLGB 45985/0233, revision 16/10/2023) — Victoza (also consulted)
European Union
- EMA: Mounjaro EPAR Product Information (English) — Mounjaro
- EMA: Wegovy EPAR Product Information — Wegovy
- EMA: Ozempic EPAR Product Information — Ozempic
- EMA: Saxenda EPAR Product Information (English) — Saxenda
- EMA: Trulicity EPAR Product Information (English) — Trulicity
- EMA: Victoza EPAR Product Information (English) — Victoza
- EMA: Victoza: EPAR (European Public Assessment Report) page, listing the current product information and its last-updated date — Victoza (also consulted)
United States
- FDA / DailyMed: Mounjaro prescribing information and patient instructions (DailyMed, current label) — Mounjaro
- FDA / DailyMed: Wegovy prescribing information and patient instructions (DailyMed, current label) — Wegovy
- FDA / DailyMed: Ozempic prescribing information and patient instructions (DailyMed, current label) — Ozempic
- FDA / DailyMed: Saxenda prescribing information and patient instructions (DailyMed, current label) — Saxenda
- FDA / DailyMed: Trulicity prescribing information and patient instructions (DailyMed, current label) — Trulicity
- FDA / DailyMed: Zepbound prescribing information and patient instructions (DailyMed, current label) — Zepbound
- FDA / DailyMed: Victoza prescribing information and patient instructions (DailyMed, current label) — Victoza
- Novo Nordisk: How to take Victoza (patient website, step by step) — Victoza (also consulted)
Documents are the manufacturers’ or regulators’ own. They are fixed files or pages that the manufacturer or regulator can change, so always check the leaflet supplied with your medicine.
Medical disclaimer
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the shading shows where you've injected before. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.